A comparison of the levels of hepatocyte growth factor in serum in patients with type 1 diabetes mellitus with different stages of diabetic retinopathy

Endokrynologia Polska

Volumn 59, Issue 1, 2008, Pages 2-5

  Nowak, Mariusz ^a   Wielkoszyński, Tomasz ^a   Marek, Bogdan ^a   Kos Kudła, Beata ^a   Świȩtochowska, Elzbieta ^a   Siemińska, Lucyna ^a   Kajdaniuk, Dariusz ^a   Głogowska Szela̧g, Joanna ^a   Nowak, Katarzyna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Diabetic retinopathy; Hepatocyte growth factor; Type 1 diabetes mellitus

Indexed keywords

SCATTER FACTOR;

ADULT; ARTICLE; BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROLIFERATIVE RETINOPATHY;

ADULT; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 42249099637     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 1993; 329: 977-986.
2. Frank RN. The aldose reductase controversy. Diabetes 1994; 43: 169-172.
3. Forester JV, Knott RM, Mc Intosh LC. Pathogenesis of proliferative diabetic retinopathy and maculopathy. Elsevier Science Publishers, Amsterdam 1993; pp 178-191.
4. Camera A, Hopps E, Caimi G. Diabetic microangiopathy: physiopathological, clinical and therapeutic aspects. Minerva Endocrinol. 2007; 3: 209-229.
5. Zhang JZ, Xi X, Gao L, Kern TS. Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy. Curr Eye Res 2007; 10: 883-889.
6. D'Amore P. Mechanisms of retinal and choroidal neovascularisation. Invest Ophth Vis Sci 1994; 35: 3974-3979.
7. Simó R, Vidal MT, García-Arumí J et al. Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study. Diabetes Res Clin Pract. 2006; 1: 36-44.
8. Umeda N, Ozaki H, Hayashi H et al. Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonangiogenic fibroproliferation. Ophthalmic Res. 2002; 1: 43-47.
9. Chiarelli F, Spagnoli A, Basciani F et al. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications. Diabet Med 2000; 17: 650-656.
10. Katsura Y, Okano T, Noritake M et al. Hepatocythe growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders. Diabetes Care 1998; 21: 1759-1763.
11. Canton A, Burgos R, Hernández C et al. Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy. Br J Ophthalmol 2000; 84: 732-735.
12. Chiarelli F, Santilli F, Mohn A. Role of growth factors in the development of diabetic complications. Horm Res 2000; 53: 53-67.
13. Bussolino F, Di Renzo MF, Ziche M et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992; 119: 629-641.
14. Nishimura M, Ikeda T, Ushiyama M et al. Increased vitreous concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy. J Clin Endocrinol Metab 1999; 84: 659-662.
15. Nishimura M, Ikeda T, Ushiyama M, Kinoshita S et al. Changes in vitreous concentrations of human hepatocyte growth factor (hHGF) in proliferative diabetic retinopathy: implications for intraocular hHGF production. Clin Sci (Lond). 2000; 98: 9-14.
16. Shinoda K, Ishida S, Kawashima S et al. Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus. Br J Ophthalmol 1999; 83: 834-837.
17. Nakamura Y, Morishita R, Higaki J et al. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. J Hypertens 1996; 14: 1967-1972.
18. Naldini L, Weidner KM, Vigna E et al. Scatter factor and hepatocytes growth factor are indistinguishable ligands for the MET receptor. EMBO J 1991; 10: 2867-2878.
19. Weidner KM, Arakaki N, Hartmann G et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA. 1991; 88: 7001-7005.
20. Gohda E, Tsubouchi H, Nakayama H et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with hepatic failure. J Clin Invest 1988; 81: 414-419.
21. Miyazawa K, Tsubouchi H, Naka D et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989; 163: 967-973.
22. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1991; 16: 1227-1235.
23. Ito T, Hayashi N, Horimoto M et al. Expression of the c-met/hepatocyte growth factor receptor gene during rat liver regeneration induced by carbon tetrachloride. Biochem Biophys Res Commun 1993; 190: 870-874.
24. Igawa T, Matsumoto K, Kanda S, Saito Y, Nakamura T. Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol 1993; 65: H61-F69.
25. Kawaida K, Matsumoto K, Shimazu H, Nakamura T. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA. 1994; 91: 4357-4361.
26. Nakamura Y, Morishita R, Higaki J et al. Expression of a local hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun 1995; 215: 483-488.
27. Nishimura M, Nakano K, Ushiyama M et al. Increased serum concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy. J Clin Endocrinol Metab 1998; 83: 195-198.
28. Canton A, Burgos R, Hernandez C et al. Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy. Br J Ophthalmol 2000; 84: 732-735.